G. Charles Robb
2011
In 2011, G. Charles Robb earned a total compensation of $1.5M as Chief Financial Officer at Corcept Therapeutics.
Compensation breakdown
| Option Awards | $1,380,000 |
|---|---|
| Salary | $100,000 |
| Total | $1,480,000 |
Robb received $1.4M in option awards, accounting for 93% of the total pay in 2011.
Robb also received $100K in salary.
Rankings
In 2011, G. Charles Robb's compensation ranked 4,264th out of 10,747 executives tracked by ExecPay. In other words, Robb earned more than 60.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,264 out of 10,747 | 60th |
Division Manufacturing | 1,511 out of 3,960 | 62nd |
Major group Chemicals And Allied Products | 308 out of 1,038 | 70th |
Industry group Drugs | 181 out of 786 | 77th |
Industry Pharmaceutical Preparations | 142 out of 571 | 75th |
Source: SEC filing on April 7, 2014.
Robb's colleagues
We found four more compensation records of executives who worked with G. Charles Robb at Corcept Therapeutics in 2011.